Hofsink, QuincyHaggenburg, SabineLissenberg-Witte, Birgit IBroers, Annoek E Cvan Doesum, Jaap Avan Binnendijk, Rob Sden Hartog, GercoBhoekhan, Michel SHaverkate, Nienke J Evan Meerloo, JohanBurger, Judith ABouhuijs, Joey HSmits, Gaby PWouters, Dorinevan Leeuwen, Ester M MBontkes, Hetty JKootstra, Neeltje AVogels-Nooijen, SandraRots, Nynkevan Beek, JosineHeemskerk, Mirjam H MGroen, Kazimierzvan Meerten, TomMutsaers, Pim G N Jvan Gils, Marit JGoorhuis, AbrahamRutten, Caroline EHazenberg, Mette DNijhof, Inger S2023-06-262023-06-262023-06-153733761610.1016/j.eclinm.2023.102040http://hdl.handle.net/10029/626789en© 2023 The Author(s).Antibody responseBooster vaccinationCOVID-19 vaccinationHaematological malignanciesImmunocompromisedSARS-CoV-2Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study.Article2589-5370EClinicalMedicine 2023;61:102040